836 related articles for article (PubMed ID: 34980884)
21. Convergence between Wnt-β-catenin and EGFR signaling in cancer.
Hu T; Li C
Mol Cancer; 2010 Sep; 9():236. PubMed ID: 20828404
[TBL] [Abstract][Full Text] [Related]
22. Wnt signalling is a bi-directional vulnerability of cancer cells.
Duffy DJ; Krstic A; Schwarzl T; Halasz M; Iljin K; Fey D; Haley B; Whilde J; Haapa-Paananen S; Fey V; Fischer M; Westermann F; Henrich KO; Bannert S; Higgins DG; Kolch W
Oncotarget; 2016 Sep; 7(37):60310-60331. PubMed ID: 27531891
[TBL] [Abstract][Full Text] [Related]
23. New avenues to target Wnt/β-catenin signaling.
Verkaar F; Zaman GJ
Drug Discov Today; 2011 Jan; 16(1-2):35-41. PubMed ID: 21111060
[TBL] [Abstract][Full Text] [Related]
24. Mathematical modelling of Wnt/β-catenin signalling.
Kofahl B; Wolf J
Biochem Soc Trans; 2010 Oct; 38(5):1281-5. PubMed ID: 20863299
[TBL] [Abstract][Full Text] [Related]
25. Targeting the Wnt/β-catenin signaling pathway in cancer.
Zhang Y; Wang X
J Hematol Oncol; 2020 Dec; 13(1):165. PubMed ID: 33276800
[TBL] [Abstract][Full Text] [Related]
26. Dysregulation of Wnt/β-catenin signaling in gastrointestinal cancers.
White BD; Chien AJ; Dawson DW
Gastroenterology; 2012 Feb; 142(2):219-32. PubMed ID: 22155636
[TBL] [Abstract][Full Text] [Related]
27. A Wnt-ow of opportunity: targeting the Wnt/beta-catenin pathway in breast cancer.
Prosperi JR; Goss KH
Curr Drug Targets; 2010 Sep; 11(9):1074-88. PubMed ID: 20545611
[TBL] [Abstract][Full Text] [Related]
28. Extracellular matrix stiffness and Wnt/β-catenin signaling in physiology and disease.
Astudillo P
Biochem Soc Trans; 2020 Jun; 48(3):1187-1198. PubMed ID: 32412078
[TBL] [Abstract][Full Text] [Related]
29. Expression of the novel Wnt receptor ROR2 is increased in breast cancer and may regulate both β-catenin dependent and independent Wnt signalling.
Henry C; Quadir A; Hawkins NJ; Jary E; Llamosas E; Kumar D; Daniels B; Ward RL; Ford CE
J Cancer Res Clin Oncol; 2015 Feb; 141(2):243-54. PubMed ID: 25209439
[TBL] [Abstract][Full Text] [Related]
30. Paracrine activation of WNT/β-catenin pathway in uterine leiomyoma stem cells promotes tumor growth.
Ono M; Yin P; Navarro A; Moravek MB; Coon JS; Druschitz SA; Serna VA; Qiang W; Brooks DC; Malpani SS; Ma J; Ercan CM; Mittal N; Monsivais D; Dyson MT; Yemelyanov A; Maruyama T; Chakravarti D; Kim JJ; Kurita T; Gottardi CJ; Bulun SE
Proc Natl Acad Sci U S A; 2013 Oct; 110(42):17053-8. PubMed ID: 24082114
[TBL] [Abstract][Full Text] [Related]
31. Flavonoids and Wnt/β-catenin signaling: potential role in colorectal cancer therapies.
Amado NG; Predes D; Moreno MM; Carvalho IO; Mendes FA; Abreu JG
Int J Mol Sci; 2014 Jul; 15(7):12094-106. PubMed ID: 25007066
[TBL] [Abstract][Full Text] [Related]
32. MicroRNAs target the Wnt/β‑catenin signaling pathway to regulate epithelial‑mesenchymal transition in cancer (Review).
Lei Y; Chen L; Zhang G; Shan A; Ye C; Liang B; Sun J; Liao X; Zhu C; Chen Y; Wang J; Zhang E; Deng L
Oncol Rep; 2020 Oct; 44(4):1299-1313. PubMed ID: 32700744
[TBL] [Abstract][Full Text] [Related]
33. Syndecan-1 promotes Wnt/β-catenin signaling in multiple myeloma by presenting Wnts and R-spondins.
Ren Z; van Andel H; de Lau W; Hartholt RB; Maurice MM; Clevers H; Kersten MJ; Spaargaren M; Pals ST
Blood; 2018 Mar; 131(9):982-994. PubMed ID: 29212806
[TBL] [Abstract][Full Text] [Related]
34. Genome-wide analysis of canonical Wnt target gene regulation in Xenopus tropicalis challenges β-catenin paradigm.
Nakamura Y; Hoppler S
Genesis; 2017 Jan; 55(1-2):. PubMed ID: 28095618
[TBL] [Abstract][Full Text] [Related]
35. Wnt/β-catenin signaling pathway in carcinogenesis and cancer therapy.
Song P; Gao Z; Bao Y; Chen L; Huang Y; Liu Y; Dong Q; Wei X
J Hematol Oncol; 2024 Jun; 17(1):46. PubMed ID: 38886806
[TBL] [Abstract][Full Text] [Related]
36. β-Catenin signaling in hepatocellular carcinoma.
Xu C; Xu Z; Zhang Y; Evert M; Calvisi DF; Chen X
J Clin Invest; 2022 Feb; 132(4):. PubMed ID: 35166233
[TBL] [Abstract][Full Text] [Related]
37. MicroRNA-449b-5p suppresses the growth and invasion of breast cancer cells via inhibiting CREPT-mediated Wnt/β-catenin signaling.
Jiang J; Yang X; He X; Ma W; Wang J; Zhou Q; Li M; Yu S
Chem Biol Interact; 2019 Apr; 302():74-82. PubMed ID: 30738779
[TBL] [Abstract][Full Text] [Related]
38. Urokinase-type plasminogen activator receptor (uPAR)-mediated regulation of WNT/β-catenin signaling is enhanced in irradiated medulloblastoma cells.
Asuthkar S; Gondi CS; Nalla AK; Velpula KK; Gorantla B; Rao JS
J Biol Chem; 2012 Jun; 287(24):20576-89. PubMed ID: 22511755
[TBL] [Abstract][Full Text] [Related]
39. Physiological β-catenin signaling controls self-renewal networks and generation of stem-like cells from nasopharyngeal carcinoma.
Cheng Y; Cheung AK; Ko JM; Phoon YP; Chiu PM; Lo PH; Waterman ML; Lung ML
BMC Cell Biol; 2013 Sep; 14():44. PubMed ID: 24073846
[TBL] [Abstract][Full Text] [Related]
40. CREPT facilitates colorectal cancer growth through inducing Wnt/β-catenin pathway by enhancing p300-mediated β-catenin acetylation.
Zhang Y; Wang S; Kang W; Liu C; Dong Y; Ren F; Wang Y; Zhang J; Wang G; To KF; Zhang X; Sung JJ; Chang Z; Yu J
Oncogene; 2018 Jun; 37(26):3485-3500. PubMed ID: 29563608
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
